Cargando…

1663. Risk-benefit assessment of cefazolin use for surgical site infection prevention among patients allergic to penicillins and cephalosporins

BACKGROUND: Prosthetic joint infection (PJI) is a devastating complication following knee and hip arthroplasty. Perioperative antibiotics are routinely used in an effort to decrease the risk of surgical site infections (SSI), including superficial skin infections and deep PJI. The American Academy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeffres, Meghan N, Porter, Melissa, Ricco, Madison, Norvell, Miranda, Hogan, Craig, Bassler, Eric, Koonce, Ryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752351/
http://dx.doi.org/10.1093/ofid/ofac492.129
_version_ 1784850701126467584
author Jeffres, Meghan N
Porter, Melissa
Ricco, Madison
Norvell, Miranda
Hogan, Craig
Bassler, Eric
Koonce, Ryan
author_facet Jeffres, Meghan N
Porter, Melissa
Ricco, Madison
Norvell, Miranda
Hogan, Craig
Bassler, Eric
Koonce, Ryan
author_sort Jeffres, Meghan N
collection PubMed
description BACKGROUND: Prosthetic joint infection (PJI) is a devastating complication following knee and hip arthroplasty. Perioperative antibiotics are routinely used in an effort to decrease the risk of surgical site infections (SSI), including superficial skin infections and deep PJI. The American Academy of Orthopedic Surgeons recommend cefazolin as standard of care for SSI prophylaxis. However, non-beta-lactams are often used in patients labeled as allergic to penicillins or cephalosporins due to concern of increased hypersensitivity reactions (HSR). METHODS: This study examined the frequency of SSI and HSR after receipt of perioperative cefazolin compared to clindamycin and/or vancomycin (C/V) within adult patients labeled as allergic to penicillins or cephalosporins. Patients were included if they underwent primary total hip or knee replacement surgery between January 2020 and July 2021 within the University of Colorado Health system. The outcome of SSI was assessed up to 90 days after surgery. The outcome of HSR was assessed up to 60 minutes after the conclusion of surgery. RESULTS: The cohort included 1,128 patients (cefazolin, n=809; C/V, n=319). Baseline characteristics were similar between groups except the proportion of patients with a history of immediate allergy symptoms was greater in the C/V group (59.6%) compared to the cefazolin group (35.8%). The frequency of SSI was lower in the cefazolin group compared to the C/V group (0.9% vs. 3.8%, p < .01). The cefazolin group included 7 SSI, consisting of 6 superficial SSI and 1 deep PJI. The C/V group included 12 SSI, consisting of 6 superficial SSI and 6 deep PJI. HSR were not significantly different between patients receiving cefazolin vs. C/V (0.2% vs. 1.3%, p=.06). HSR in the cefazolin group consisted of skin involvement (n=1) and self-reported allergy in post-operative window (n=1). Both patients had a non-descript history of penicillin allergy. HSR in the C/V group consisted of skin involvement (n=2) and hemodynamic instability (n=2). Three of the four patients had a history of immediate cephalosporin allergy. CONCLUSION: Among penicillin or cephalosporin allergic patients, the use of cefazolin was associated with a lower frequency of PJI without an increase in HSR during surgery. DISCLOSURES: All Authors: No reported disclosures.
format Online
Article
Text
id pubmed-9752351
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-97523512022-12-16 1663. Risk-benefit assessment of cefazolin use for surgical site infection prevention among patients allergic to penicillins and cephalosporins Jeffres, Meghan N Porter, Melissa Ricco, Madison Norvell, Miranda Hogan, Craig Bassler, Eric Koonce, Ryan Open Forum Infect Dis Abstracts BACKGROUND: Prosthetic joint infection (PJI) is a devastating complication following knee and hip arthroplasty. Perioperative antibiotics are routinely used in an effort to decrease the risk of surgical site infections (SSI), including superficial skin infections and deep PJI. The American Academy of Orthopedic Surgeons recommend cefazolin as standard of care for SSI prophylaxis. However, non-beta-lactams are often used in patients labeled as allergic to penicillins or cephalosporins due to concern of increased hypersensitivity reactions (HSR). METHODS: This study examined the frequency of SSI and HSR after receipt of perioperative cefazolin compared to clindamycin and/or vancomycin (C/V) within adult patients labeled as allergic to penicillins or cephalosporins. Patients were included if they underwent primary total hip or knee replacement surgery between January 2020 and July 2021 within the University of Colorado Health system. The outcome of SSI was assessed up to 90 days after surgery. The outcome of HSR was assessed up to 60 minutes after the conclusion of surgery. RESULTS: The cohort included 1,128 patients (cefazolin, n=809; C/V, n=319). Baseline characteristics were similar between groups except the proportion of patients with a history of immediate allergy symptoms was greater in the C/V group (59.6%) compared to the cefazolin group (35.8%). The frequency of SSI was lower in the cefazolin group compared to the C/V group (0.9% vs. 3.8%, p < .01). The cefazolin group included 7 SSI, consisting of 6 superficial SSI and 1 deep PJI. The C/V group included 12 SSI, consisting of 6 superficial SSI and 6 deep PJI. HSR were not significantly different between patients receiving cefazolin vs. C/V (0.2% vs. 1.3%, p=.06). HSR in the cefazolin group consisted of skin involvement (n=1) and self-reported allergy in post-operative window (n=1). Both patients had a non-descript history of penicillin allergy. HSR in the C/V group consisted of skin involvement (n=2) and hemodynamic instability (n=2). Three of the four patients had a history of immediate cephalosporin allergy. CONCLUSION: Among penicillin or cephalosporin allergic patients, the use of cefazolin was associated with a lower frequency of PJI without an increase in HSR during surgery. DISCLOSURES: All Authors: No reported disclosures. Oxford University Press 2022-12-15 /pmc/articles/PMC9752351/ http://dx.doi.org/10.1093/ofid/ofac492.129 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Jeffres, Meghan N
Porter, Melissa
Ricco, Madison
Norvell, Miranda
Hogan, Craig
Bassler, Eric
Koonce, Ryan
1663. Risk-benefit assessment of cefazolin use for surgical site infection prevention among patients allergic to penicillins and cephalosporins
title 1663. Risk-benefit assessment of cefazolin use for surgical site infection prevention among patients allergic to penicillins and cephalosporins
title_full 1663. Risk-benefit assessment of cefazolin use for surgical site infection prevention among patients allergic to penicillins and cephalosporins
title_fullStr 1663. Risk-benefit assessment of cefazolin use for surgical site infection prevention among patients allergic to penicillins and cephalosporins
title_full_unstemmed 1663. Risk-benefit assessment of cefazolin use for surgical site infection prevention among patients allergic to penicillins and cephalosporins
title_short 1663. Risk-benefit assessment of cefazolin use for surgical site infection prevention among patients allergic to penicillins and cephalosporins
title_sort 1663. risk-benefit assessment of cefazolin use for surgical site infection prevention among patients allergic to penicillins and cephalosporins
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752351/
http://dx.doi.org/10.1093/ofid/ofac492.129
work_keys_str_mv AT jeffresmeghann 1663riskbenefitassessmentofcefazolinuseforsurgicalsiteinfectionpreventionamongpatientsallergictopenicillinsandcephalosporins
AT portermelissa 1663riskbenefitassessmentofcefazolinuseforsurgicalsiteinfectionpreventionamongpatientsallergictopenicillinsandcephalosporins
AT riccomadison 1663riskbenefitassessmentofcefazolinuseforsurgicalsiteinfectionpreventionamongpatientsallergictopenicillinsandcephalosporins
AT norvellmiranda 1663riskbenefitassessmentofcefazolinuseforsurgicalsiteinfectionpreventionamongpatientsallergictopenicillinsandcephalosporins
AT hogancraig 1663riskbenefitassessmentofcefazolinuseforsurgicalsiteinfectionpreventionamongpatientsallergictopenicillinsandcephalosporins
AT basslereric 1663riskbenefitassessmentofcefazolinuseforsurgicalsiteinfectionpreventionamongpatientsallergictopenicillinsandcephalosporins
AT koonceryan 1663riskbenefitassessmentofcefazolinuseforsurgicalsiteinfectionpreventionamongpatientsallergictopenicillinsandcephalosporins